Advances in Disease X preparedness
Learn how CEPI and Japan are preparing for Disease X.
Join us to hear three presentations on current preparations for Disease X.
CEPI’s 100 Days Mission and Disease X by Dr Mitsutaka Kitano
The 100 Days Mission is CEPI’s ambitious vision to reduce the time from identification of an emerging pathogen, including the unknown Disease X, to the deployment of safe, effective, and globally accessible vaccines within 100 days. This presentation explores how CEPI is advancing this goal through prototype vaccine libraries, pre-approved clinical trial and regulatory frameworks, flexible manufacturing capacity, and data-driven surveillance and early-warning systems. By integrating these elements, CEPI aims to transform pandemic preparedness from a reactive to an anticipatory model, leveraging scientific innovation and multidisciplinary collaboration.
Building Global AI Platform for Pandemic Preparedness by Dr Polina Brangel
Under CEPI’s Disease X programme, a global AI platform is being developed to strengthen pandemic preparedness by integrating data from viral genomics, structural biology, immunology, epidemiology, and vaccine development pipelines into a unified analytical framework. The goal is to enable researchers and partners worldwide to generate, test, and share predictive models that can inform vaccine design for outbreak response more rapidly and effectively.
This talk will outline the platform’s architecture and technical layers. It will cover approaches for data selection and prioritisation and explain why we aim to integrate both pathogen monitoring data and laboratory findings, such as immune-response profiles. The presentation will also highlight how the platform supports work across different global regions, as well as addressing challenges related to biosecurity and equitable access.
Japan Institute for Health Security by Dr Motoi Suzuki
In April 2025, Japan established the Japan Institute for Health Security (JIHS) through the integration of the National Institute of Infectious Diseases (NIID) and the National Center for Global Health and Medicine (NCGM), reflecting lessons learned from the COVID-19 pandemic. JIHS was created to serve as a comprehensive infectious disease science center, integrating infectious disease epidemiology, surveillance, clinical medicine, and vaccine and therapeutic research and development to strengthen preparedness for future health crises.
This presentation will outline the mission and core functions of JIHS, with a focus on strengthening international collaboration in infectious disease epidemiology and vaccine research and development.
Speakers
Dr Mitsutaka Kitano
Dr Mitsutaka Kitano is a Project Leader at the Coalition for Epidemic Preparedness Innovations (CEPI), where he leads several projects under the Disease X Vaccine Library Program, focusing on accelerating vaccine development for future epidemic threats.
Dr Polina Brangel
Dr Polina Brangel is a Disease X Programme Manager within CEPI Research and Development Division. She also leads data infrastructure development for the Pandemic Preparedness Engine, applying AI to accelerate vaccine research.
Dr Motoi Suzuki
Dr Motoi Suzuki is the Director of the Center for Infectious Disease Epidemiology at the National Institute of Infectious Diseases, Japan, and also heads the Department of Infectious Disease Epidemiology at the Japan Institute for Health Security. He has more than two decades of experience in infectious disease epidemiology and global health, with a particular focus on infectious disease surveillance and vaccine epidemiology.
Event notices
- Please note that you can join this event in person or you can join the session remotely
- Please note that the recording link will be listed on this page when available
Admission
Contact
